Resmed IncNYSE:RMD
- LAST PRICE249.9700
- TODAY'S CHANGE (%)0.6400 (0.2567%)
- Bid / Lots249.9200/ 8
- Ask / Lots250.2500/ 8
- Open / Previous Close248.4700 / 249.3300
- Day Range
- 52 Week Range
- Volume103,708
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RMD |
|---|---|---|
| 09:32 ET | 6872 | 249.05 |
| 09:33 ET | 103 | 248.015 |
| 09:35 ET | 900 | 248.595 |
| 09:37 ET | 375 | 249.55 |
| 09:39 ET | 507 | 249.235 |
| 09:42 ET | 100 | 249.235 |
| 09:44 ET | 1858 | 249.955 |
| 09:46 ET | 1650 | 250.03 |
| 09:48 ET | 200 | 250.325 |
| 09:50 ET | 500 | 249.71 |
| 09:51 ET | 1957 | 249.62 |
| 09:53 ET | 1295 | 250.38 |
| 09:55 ET | 100 | 250.345 |
| 09:57 ET | 208 | 250.32 |
| 10:00 ET | 201 | 250.32 |
| 10:02 ET | 1138 | 250.48 |
| 10:04 ET | 500 | 250.375 |
| 10:06 ET | 902 | 250.7 |
| 10:08 ET | 1110 | 251.21 |
| 10:09 ET | 408 | 251.355 |
| 10:11 ET | 335 | 251.295 |
| 10:13 ET | 1283 | 251.75 |
| 10:15 ET | 1331 | 252.36 |
| 10:18 ET | 613 | 251.86 |
| 10:20 ET | 200 | 251.77 |
| 10:22 ET | 500 | 251.465 |
| 10:24 ET | 200 | 251.6 |
| 10:26 ET | 100 | 251.69 |
| 10:27 ET | 1048 | 251.75 |
| 10:31 ET | 736 | 251.37 |
| 10:33 ET | 100 | 251.15 |
| 10:36 ET | 103 | 251.195 |
| 10:38 ET | 100 | 251.155 |
| 10:42 ET | 601 | 251.31 |
| 10:44 ET | 300 | 251.36 |
| 10:45 ET | 724 | 250.58 |
| 10:47 ET | 211 | 250.6 |
| 10:49 ET | 300 | 250.78 |
| 10:51 ET | 874 | 250.5205 |
| 10:54 ET | 100 | 250.56 |
| 10:56 ET | 207 | 250.6 |
| 10:58 ET | 100 | 250.42 |
| 11:00 ET | 200 | 250.401 |
| 11:02 ET | 1000 | 250.565 |
| 11:03 ET | 691 | 250.565 |
| 11:05 ET | 1527 | 250.3701 |
| 11:07 ET | 1787 | 250.18 |
| 11:09 ET | 200 | 249.865 |
| 11:12 ET | 200 | 249.84 |
| 11:14 ET | 300 | 249.84 |
| 11:16 ET | 1477 | 249.875 |
| 11:18 ET | 1515 | 249.89 |
| 11:21 ET | 820 | 249.8 |
| 11:25 ET | 100 | 250.03 |
| 11:27 ET | 520 | 250.0603 |
| 11:30 ET | 226 | 250.05 |
| 11:32 ET | 100 | 249.79 |
| 11:34 ET | 253 | 249.98 |
| 11:36 ET | 160 | 249.89 |
| 11:38 ET | 300 | 250.12 |
| 11:39 ET | 783 | 250 |
| 11:43 ET | 807 | 249.91 |
| 11:52 ET | 100 | 249.995 |
| 11:54 ET | 500 | 250.05 |
| 11:56 ET | 556 | 249.91 |
| 11:57 ET | 412 | 249.89 |
| 11:59 ET | 852 | 249.95 |
| 12:01 ET | 447 | 249.94 |
| 12:06 ET | 100 | 249.97 |
Nov 6, 2024
DJ U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk, from 10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones
10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
ResMed Announces Participation in the UBS Global Healthcare Conference, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Resmed Inc | 36.6B | 33.1x | +19.48% |
Agilent Technologies Inc | 39.4B | 43.0x | --- |
Edwards Lifesciences Corp | 42.5B | 30.1x | +14.85% |
Veeva Systems Inc | 36.7B | 59.3x | +17.29% |
Illumina Inc | 22.7B | -14.4x | --- |
Hologic Inc | 18.0B | 23.9x | --- |
Company Information
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Company’s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.
Contact Information
- Headquarters
- 9001 Spectrum Center BlvdSAN DIEGO, CA, United States 92123-1438
- Phone
- 858-746-2400
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer
- Michael Farrell
- Founder and Chairman Emeritus
- Peter Farrell
- Chief Financial Officer
- Brett Sandercock
- Global General Counsel, Company Secretary
- Michael Rider
- Chief Commercial Officer - SaaS
- Bobby Ghoshal
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $36.6B |
|---|---|
Revenue (TTM) | $4.8B |
Shares Outstanding | 146.8M |
Dividend Yield | 0.85% |
Annual Dividend Rate | 2.1200 USD |
Ex-Dividend Date | 11-07-24 |
Pay Date | 12-12-24 |
Beta | 0.69 |
EPS | $7.54 |
Book Value | $33.11 |
P/E Ratio | 33.1x |
Price/Sales (TTM) | 7.6 |
Price/Cash Flow (TTM) | 28.4x |
Operating Margin | 29.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
